
    
      Study conduct according to the standard operating procedure

        -  The sponsor, the investigator, and all other persons involved in the study at the study
           center or other facilities should conduct the study in accordance with the study
           protocol, each standard operating procedure, and Korea Good Clinical Pratice.

      Data quality control

        -  In order to ensure the reliability of all study-related data and their appropriate
           processing, the sponsor will apply quality control to each step of data handling

      Monitoring

        -  In order to confirm that the study is being conducted, recorded and reported according
           to the study protocol and International Conference on Harmonization Good Clinical
           Practice(ICH-GCP), the sponsor or CRO will perform monitoring of study procedure. In
           monitoring, the monitors will cross check the description in the case report form, etc.
           against study-related records such as source documents to confirm that the description
           is accurate.

      Measures taken to cope with adverse events and reporting procedure

        -  The investigator should notify the event to the sponsor or Contract Research
           Organization(CRO) immediately (within around 24 hours) after having noticed the
           occurence of a serioius adverse event by telephone, fax or E-mail. The investigator
           should complete and submit an serioius adverse event(SAE) report form containing all
           information to the Institutional Review Board (IRB).

      Data Management

        -  In this study, data will be collected in electronic Case Report Form(CRF)

        -  Data validation for missing data will be managed by computer programming and manual
           check.
    
  